Table I.

Serum and stool IL-1β, IL-1ra and IL-6 concentrations and IL-1ra/IL-1β ratio in active and inactive UC and control groups at the beginning of the study

Parameter	Active UC group (n = 20)	Inactive UC group (n = 18)	Control group (n = 14)
IL-1β [pg/ml]:
Serum	1.05 (0.38–2.69)*	0.87 (0.39–1.9)	0.33 (0.11–1.0)
Stool	393.7 (55.5–855)*	9.1 (5.2–21.3)	13.5 (6.9–22.6)
IL-1ra [pg/ml]:
Serum	532.1 (135.4–898.4)*	418.1 (205–946.9)	322.5 (183–737)
Stool	4950.3 (910.7–6525)*	406.9 (131.3–835)	678.5 (242–1570)
IL-1ra/IL-1β ratio:
Serum	450.4 (267.4–1287)*	535.0 (225–1108)	856 (367–2233)
Stool	10.8 (6–32)*	45.7 (9.2–76.6)	47.5 (14–115)
IL-6 [pg/ml]:
Serum	5.8 (1.3–10.7)*	2.1 (0.37–7.5)	2.7 (0.54–6)
Stool	13 (4.6–31.8)*	11.3 (1.6–29.9)	14.6 (9.9–33)

Results are presented as median values and ranges.

^*P < 0.05 when compared to inactive UC and control group.